Tech Company Financing Transactions
Tomorrow Biostasis Funding Round
Tomorrow Biostasis, based in Berlin, scored $5.7 million from Blast.Club, TruVenturo and private investors.
Transaction Overview
Company Name
Announced On
5/26/2025
Transaction Type
Venture Equity
Amount
$5,700,000
Round
Undisclosed
Investors
Blast.Club (Lead Investor)
TruVenturo (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand into Europe and the United States, as well as to continue to extend its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Graefestr. 11
Berlin, 10967
Germany
Berlin, 10967
Germany
Phone
Website
Email Address
Overview
We're a team of doctors, engineers, and technologists -- optimistic about the science of cryopreservation. Tomorrow.bio was founded to further biostasis science and provide high-quality cryopreservation in the heart of Europe and now continental USA. Mission: To spread awareness and inform people openly about the option of cryopreservation. To offer a high-quality service. And to conduct and fund research to further the field of cryonics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emil Kendziorra
Chief Operating Officer
Fernando Pinheiro
VP - Engineering
Sako Jola
Browse more venture capital transactions:
Prev: 5/26/2025: Optura venture capital transaction
Next: 5/27/2025: Surgify Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs